San Marino

São Tomé e Príncipe

United States

Australia

Austria

Belgium

Brazil

Canada

Czech Republic

Date of Revision

Denmark

Ecuador

France

French Guiana

French Polynesia

French Southern Territories

Gabon

Gambia

Georgia

Germany

Ghana

Gibraltar

Greece

Greenland

Grenada

Guadeloupe

Guam

Guatemala

Guernsey

Guinea

Guinea-Bissau

Guyana

Haiti

Heard Island and McDonald Islands

Honduras

Hong Kong SAR of China

Hungary

Hybrid

Iceland

India

Indonesia

Iran

Iraq

Ireland

Isle of Man

Israel

Italy

Jamaica

Japan

Jersey

Jordan

Kazakhstan

Kenya

Kiribati

Kuwait

Kyrgyzstan

Laos

Latvia

Lebanon

Lesotho

Liberia

Libya

Liechtenstein

Lithuania

Luxembourg

Macao SAR of China

Macedonia

Madagascar

Malawi

Malaysia

Maldives

Mali

Malta

Marshall Islands

Martinique

Mauritania

Mauritius

Mayotte

Mexico

Micronesia

Moldova

Monaco

Mongolia

Montenegro

Montserrat

Morocco

Mozambique

Myanmar

Namibia

Nauru

Nepal

Netherlands

New Caledonia

New Zealand

Nicaragua

Niger

Nigeria

Niue

Norfolk Island

North Korea

4F-PCC

Albumin

Anticoagulation

Antithrombin

Bleeding management

Brochure

CAR T-cell therapy

Cardiac surgery

Careers

Coagulation monitoring

Coagulopathy

COVID-19

Critical Care

Diseases & Therapies

Distribution and supply chain

DOACs

Donors

Download material

Drug Safety

Endotheliopathy

Engaging with patients

ESLD

Events

Factor concentrates

Fibrinogen

Fluid resuscitation

FXa inhibitors

Haematological malignancies

Haemostasis

Haematology

Haemophilia

Hypofibrinogenaemia

Ig replacement therapy

IgG administration

Immunology

IVIG

Liver cirrhosis

Massive bleeding

Multiple myeloma

Neurological disorders

Obstetric bleeding

Paediatric

Panzyga®

Patient stories

Plasma

Platelets derangement

Pre-hospital

Product reconstitution

Production process

Prothrombin Complex Concentrate

Research & Development

Reversal of OAC

Rheumatic disorders

ROTEM

Secondary immune deficiency

Thrombin generation

Thromboembolic complications

Traceability

Transfusion

Transplantation

Trauma

Vitamin K antagonist

von Willebrand disease

Women in Science

Annual Report

АЛЬБУМИН

Ready to make a difference? We encourage you to explore our open positions.

Job Openings

Current jobs available for Octapharma Canada

[YOUR MESSAGE]%0D%0A%0D%0A%0D%0ALocation: ${location}%0D%0A%0D%0AReport:%0D%0A${report}

Job Openings

About us

Plasma

Therapies

Working with us

News